...
首页> 外文期刊>International journal of molecular medicine >20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginsenoside Rb1, enhances the production of hyaluronic acid through the activation of ERK and Akt mediated by Src tyrosin kinase in human keratinocytes
【24h】

20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginsenoside Rb1, enhances the production of hyaluronic acid through the activation of ERK and Akt mediated by Src tyrosin kinase in human keratinocytes

机译:人参皂甙Rb1的代谢产物20-O-β-D-吡喃葡萄糖基20(S)-普萘他那二醇通过人角质形成细胞中Src酪氨酸激酶介导的ERK和Akt的活化增强透明质酸的产生

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to determine the mechanisms through which 20-O-beta-D-glucopyranosy120(S)-protopanaxadiol (20GPPD) promotes the production of hyaluronic acid (HA) in human keratinocytes. 20GPPD is the primary bioactive metabolite of Rb1, a major ginsenoside found in ginseng (Panax ginseng). We sought to elucidate the underlying mechanisms behind the 20GPPD-induced production of HA. We found that 20GPPD induced an increase in HA production by elevating hyaluronan synthase 2 (HAS2) expression in human keratinocytes. The phosphorylation of extracellular signal-regulated kinase (ERK) and Akt was also enhanced by 20GPPD in a dose-dependent manner. The pharmacological inhibition of ERK (using U0126) or Akt (using LY294002) suppressed the 20GPPD-induced expression of HAS2, whereas treatment with an epidermal growth factor receptor (EGFR) inhibitor (AG1478) or an intracellular Ca2+ chelator (BAPTA/AM) did not exert any observable effects. The increased Src phosphorylation was also confirmed following treatment with 20GPPD in the human keratinocytes. Following pre-treatment with the Src inhibitor, PP2, both HA production and HAS2 expression were attenuated. Furthermore, the 20GPPD-enhanced ERK and Akt signaling decreased following treatment with PP2. Taken together, our results suggest that Src kinase plays a critical role in the 20GPPD-induced production of HA by acting as an upstream modulator of ERK and Akt activity in human keratinocytes.
机译:本研究的目的是确定通过机制20-O-β-D-吡喃葡萄糖基120(S)-原庚二醇(20GPPD)促进人角质形成细胞中透明质酸(HA)的产生。 20GPPD是Rb1的主要生物活性代谢物,Rb1是人参(Panax ginseng)中发现的主要人参皂甙。我们试图阐明20GPPD诱导的HA生产背后的潜在机制。我们发现20GPPD通过提高人角质形成细胞中的透明质酸合酶2(HAS2)表达来诱导HA产生增加。 20GPPD还以剂量依赖的方式增强了细胞外信号调节激酶(ERK)和Akt的磷酸化。 ERK(使用U0126)或Akt(使用LY294002)的药理抑制作用抑制了20GPPD诱导的HAS2的表达,而用表皮生长因子受体(EGFR)抑制剂(AG1478)或细胞内Ca2 +螯合剂(BAPTA / AM)处理确实没有发挥任何明显的作用。在人角质形成细胞中用20GPPD处理后,也证实了Src磷酸化的增加。用Src抑制剂PP2预处理后,HA产生和HAS2表达均减弱。此外,在用PP2处理后,增强了20GPPD的ERK和Akt信号转导。两者合计,我们的结果表明Src激酶通过充当人类角质形成细胞中ERK和Akt活性的上游调节剂,在20GPPD诱导的HA产生中发挥关键作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号